Nordic Bioscience har en filosofi. Biotekselskabet satser på tidlige partnerskabsaftaler, nægter at rejse kapital hos aktionærerne og sørger for ikke at brænde pengene op med det samme. Ny serie tager fat i de biotekfirmaer, der rent faktisk tjener penge.
Som et af de få danske selskaber afsluttede Nordic Bioscience 2010 med sorte tal på bundlinjen. Årsagen til overskuddet er enkel – biotekselskabet gør en dyd ud af at spare på kapitalen for at have penge i tanken til senere forskningsprojekter.
Allerede abonnent? Log Ind.
Kvalitetschef, QP/RP til Specific Pharma A/S 
Head of Staff & Project Management - Orphazyme .png)
Head of PR/Communication – MC2 Therapeutics A/S Senior Manager, Master Planner - Orphazyme 
Clinical Trial Manager, Clinical Operations - Symphogen Director of Quality Assurance Operations - Orphazyme 
Senior Manager Business Development - Ascelia Pharma Senior Medical Writer - Orphazyme 
Global Pharmaceutical Expert – Europe, Regulatory Affairs - KHIDI 
Trial Project Manager to lead global clinical trials in a time of great change - Novo Nordisk 
Udstyrskemiker til Aseptic Production, Equipment Team – 2 årlig stilling - ALK 
Associate CMC Project Manager - Genmab 
Quality Assurance Specialist - Orifarm Director CMC - Orphazyme Senior Sustainability Manager - ALK 
Global Sales Manager – MC2 Therapeutics 
CMC Specialist at VarmX BV Infrastructure Director - Genmab Senior Manager, QA GMP - Genmab 
Manufacturing Scientist - FUJIFILM Diosynth Biotechnologies 
QA Projektleder for implementering af SAP S/4 HANA - Nomeco Brand and Marketing Manager, biomee™ – MC2 Therapeutics 
BRIDGE – Translational Excellence Programme: Call for Outstanding Postdocs and Experienced Mentors interested in Translational Medicine International Portfolio Manager - Orifarm 
Senior Scientist in Molecular Pharmacology - Zealand Pharma Global Pharmaceutical Expert – Europe, Business Development & Licensing - KHIDI Senior contract Manager - Genmab 
Experienced Scientist - LEO Pharma Erfaren udstyrskemiker til Aseptic Production, Equipment Team - ALK Manager of Medical Writing - Orphazyme Global Head of QA - Orphazyme Director of Clinical Quality Assurance Operations – Orphazyme Trial Start-up Manager specialised in start-up activities to prepare and improve our clinical trials - Novo Nordisk 
Vice President Global Quality Assurance and Regulatory Affairs – Etac Group Principal Scientist - Symphogen Pioneering Drug Delivery Expert - LEO Pharma 
CMC Regulatory Affairs Manager - Bavarian Nordic 
Regulatory Affairs Specialist - Contura 
QA Manager - Ascendis Pharma Director of Quality Systems & Compliance - Orphazyme 
Director Pharmacology & New Target Discovery - Y-mAbs 
